“I wish it’s true but no drug is ever that good.”
I can already imagine class action lawsuites over the side effects.
I can already imagine class action lawsuites over the side effects.
...
It’s being tested for safety. About a third of patients had brain inflammation, but it went away. Other monoclonal antibodies failed because of inflammation.
The positive effect of this drug seems to be correlated with dosage, so it’s promising.